Stoke Therapeutics, Inc. STOK
26.81 USD -0.12 (-0.45%)
Regular-session close
27.40 +0.59 +2.20%
After hours · Nov 20, 4:34 PM ET
25.94 Day range 27.78
22.50 52-week range 38.35
- YTD
- -15.53%
- 1 year
- -4.01%
STOK revenue history
Revenue is income from the company’s ordinary business activities.
184,420,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 184,420,000 | 147,865,000 | 404.50% |
| FY 2024 | 2024-12-31 | 36,555,000 | 27,775,000 | 316.34% |
| FY 2023 | 2023-12-31 | 8,780,000 | -3,625,000 | -29.22% |
| FY 2022 | 2022-12-31 | 12,405,000 | 12,405,000 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
